Alzheimer's drug hailed as momentous breakthrough
A major trial of an experimental dementia drug has shown - for the first time - that the progression of early stage Alzheimer鈥檚 disease can be slowed down.
Nearly 2,000 people took part in the trial, in which the drug - called Lecanemab - was infused into the body every two weeks. Researchers found it slowed cognitive decline in patients with early stage Alzheimer鈥檚 by about a quarter over eighteen months.
Kate Lee is the Chief Executive of the Alzheimer's Society in the UK. She told Newsday: 鈥淚t鈥檚 not a cure and it can鈥檛 reverse the effects of Alzheimer鈥檚鈥t can slow down the progression of the disease if we catch it very early in people.鈥�
(Picture: Shows CAT scans of brain impacted by Alzheimer's disease. Credit: Getty Images.)
Duration:
This clip is from
More clips from Newsday
-
![]()
'I immediately called my mother, I told her that I was alive'
Duration: 02:21
-
![]()
'People on both sides have suffered enough'
Duration: 04:44
